Follow the Money: AI-Powered Drug Discovery, Remote Access Labs
July 1, 2021 July 1, 2021 | Insilico Medicine closes a Series C for AI-powered drug discovery, while other investments fuel remote access labs, natural products, high throughput screening, and more. $550M: VC Fund for Therapeutics for Unmet Needs venBio has announced the closing of venBio Global Strategic Fund IV, LP (โvenBio Fund IVโ), its fourth life sciences venture capital fund, exceeding its target and closing on approximately $550 million in capital commitments in an over...
Source: bio-itworld.com